IMNM
Immunome Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.97
+0.17%0
Insider buys (3m)
18
Insider sells (3m)
-$14.9M
Net value (3m)
+22.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Higgins Jack · officer: Chief Scientific Officer | Sale | 13,200 | $25 |
| Sep 15, 2026 | Higgins Jack · officer: Chief Scientific Officer | M-Exempt | 18,000 | $1.35 |
| Aug 12, 2026 | Barchas Isaac · director | Sale | 62,291 | $26 |
| Aug 12, 2026 | Barchas Isaac · director | Sale | 11,048 | $27 |
| Aug 12, 2026 | Barchas Isaac · director | Sale | 10,125 | $26 |
| Aug 10, 2026 | Barchas Isaac · director | Sale | 20,840 | $26 |
| Aug 10, 2026 | Barchas Isaac · director | Sale | 15,248 | $26 |
| Aug 6, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | M-Exempt | 50,366 | $13 |
| Aug 6, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | Sale | 90,616 | $25 |
| Aug 6, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | M-Exempt | 40,250 | $11 |
| Jul 27, 2026 | Stoneman Sandra G. · officer: CHIEF LEGAL OFFICER & GC | A-Award | 38,250 | $0.00 |
| Jul 27, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | A-Award | 31,250 | $0.00 |
| Jul 27, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | A-Award | 62,500 | $22 |
| Jul 27, 2026 | Tsai Philip · officer: Chief Technical Officer | A-Award | 38,250 | $0.00 |
| Jul 27, 2026 | SIEGALL CLAY B · director, officer: President and CEO | A-Award | 360,000 | $22 |
| Jul 27, 2026 | SIEGALL CLAY B · director, officer: President and CEO | A-Award | 180,000 | $0.00 |
| Jul 27, 2026 | Lechleider Robert · officer: Chief Medical Officer | A-Award | 108,000 | $22 |
| Jul 27, 2026 | Lechleider Robert · officer: Chief Medical Officer | A-Award | 54,000 | $0.00 |
| Jul 27, 2026 | Rosett Max · officer: Chief Financial Officer | A-Award | 94,500 | $22 |
| Jul 27, 2026 | Rosett Max · officer: Chief Financial Officer | A-Award | 47,250 | $0.00 |
| Jul 27, 2026 | Higgins Jack · officer: Chief Scientific Officer | A-Award | 76,500 | $22 |
| Jul 27, 2026 | Higgins Jack · officer: Chief Scientific Officer | A-Award | 38,250 | $0.00 |
| Jul 27, 2026 | Stoneman Sandra G. · officer: CHIEF LEGAL OFFICER & GC | A-Award | 76,500 | $22 |
| Jul 27, 2026 | Tsai Philip · officer: Chief Technical Officer | A-Award | 76,500 | $22 |
| Jul 9, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | Sale | 1,092 | $25 |
| Jul 9, 2026 | Horn Kinney · officer: CHIEF BUSINESS OFFICER | M-Exempt | 1,092 | $13 |
| Jul 7, 2026 | Lechleider Robert · officer: Chief Medical Officer | Sale | 22,714 | $22 |
| Jul 7, 2026 | Lechleider Robert · officer: Chief Medical Officer | Sale | 16,214 | $23 |
| Jul 7, 2026 | Lechleider Robert · officer: Chief Medical Officer | Sale | 16,072 | $23 |
| Jul 7, 2026 | Barchas Isaac · director | Sale | 16,906 | $24 |
Institutional positioning
13F filings over the trailing two quarters
New 80Increased 151Reduced 112Sold out 28
| Filer | Action | Shares | Filed |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | Increased | 19,676,883 | Aug 14, 2026 |
| FMR LLC | Increased | 16,987,553 | Aug 13, 2026 |
| FMR LLC | Increased | 16,969,954 | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 16,364,011 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,805,492 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 8,168,674 | May 13, 2026 |
| REDMILE GROUP, LLC | Reduced | 5,558,885 | May 15, 2026 |
| STATE STREET CORP | Increased | 5,494,625 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 5,399,901 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 5,210,216 | Aug 14, 2026 |
| Redmile Group, LLC | Reduced | 4,911,590 | Aug 14, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 4,788,231 | May 11, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4,731,977 | May 15, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 4,581,431 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,551,289 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026